Castle Biosciences (CSTL)
(Delayed Data from NSDQ)
$19.31 USD
+0.11 (0.57%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $19.28 -0.03 (-0.16%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: AMC |
3/2024 | $-0.37 | 0.00% |
Earnings Summary
For their last quarter, Castle Biosciences (CSTL) reported earnings of -$0.10 per share, beating the Zacks Consensus Estimate of $-0.84 per share. This reflects a positive earnings surprise of 88.10%. Look out for CSTL's next earnings release on May 02, 2024. For the next earning release, we expect the company to report earnings of -$0.37 per share, reflecting a year-over-year increase of 66.36%.
Earnings History
Price & Consensus
Zacks News for CSTL
Castle Biosciences, Inc. (CSTL) Reports Q4 Loss, Tops Revenue Estimates
CSTL: What are Zacks experts saying now?
Zacks Private Portfolio Services